KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 71 filers reported holding KALVISTA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,815,000 | -25.7% | 500,000 | -30.6% | 1.57% | +1.0% |
| Q2 2023 | $6,480,000 | -10.7% | 720,000 | -22.0% | 1.55% | -28.7% |
| Q1 2023 | $7,256,352 | +16.3% | 923,200 | 0.0% | 2.17% | +0.1% |
| Q4 2022 | $6,240,832 | -30.1% | 923,200 | +96.3% | 2.17% | +86.1% |
| Q4 2020 | $8,929,000 | +52.3% | 470,203 | 0.0% | 1.17% | +1.7% |
| Q3 2020 | $5,863,000 | +5.0% | 470,203 | +1.9% | 1.15% | +1.7% |
| Q2 2020 | $5,584,000 | +224.5% | 461,500 | +105.1% | 1.13% | +147.4% |
| Q1 2020 | $1,721,000 | – | 225,000 | – | 0.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Saturn V Capital Management LP | 1,810,246 | $17,432,669 | 7.30% |
| TCG Crossover Management, LLC | 3,395,495 | $32,698,617 | 4.82% |
| TANG CAPITAL MANAGEMENT LLC | 3,440,345 | $33,130,522 | 4.68% |
| VR Adviser, LLC | 2,916,667 | $28,087,503 | 2.96% |
| Frazier Life Sciences Management, L.P. | 3,238,859 | $31,190,212 | 2.07% |
| Nan Fung Group Holdings Ltd | 234,573 | $2,258,938 | 1.83% |
| DAFNA Capital Management LLC | 605,532 | $5,831,273 | 1.81% |
| Opaleye Management Inc. | 500,000 | $4,815,000 | 1.57% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 530,400 | $5,107,752 | 1.55% |
| MPM BioImpact LLC | 577,958 | $5,565,736 | 1.49% |